Literature DB >> 35694101

Enteral nutrition provides favorable postoperative outcomes for patients with pseudomyxoma peritonei: a retrospective study.

Xuechun Kuang1,2, Guie She1,2, Yanhui Shi1,2, Zhiyou Yang1,2, Jun Li2, Zhipeng Zhang1.   

Abstract

Background: Pseudomyxoma peritonei (PMP) is a rare malignancy, and many uncertainties regarding its treatment and prognosis still remain. The main treatment for PMP is cytoreductive surgery (CRS) combined with heated intraperitoneal chemotherapy (HIPEC), which can lead to intra-abdominal trauma and systemic reactions. Enteral nutrition (EN) is an important and beneficial perioperative option for major complicated abdominal surgery compared with total parenteral nutrition (TPN). However, the role of EN in PMP after surgery is still unknown. The purpose of this study was to analyze the effects of EN on postoperative outcomes in PMP patients.
Methods: The perioperative clinical data of PMP patients from Xiangya Hospital of Central South University who accepted CRS plus HIPEC from January 2011 to December 2018 were collected and analyzed. The effects of EN on the nutritional status, postoperative complications, and hospital stay time of patients with PMP were studied. We further analyzed the risk factors affecting hospital stay and complications in PMP patients after surgery.
Results: A total of 51 PMP patients accepted CRS and were enrolled in this study, including 25 cases in the EN group and 26 patients in the TPN group. The baseline demographic characteristics and preoperative nutritional status were not significantly different between the two groups. The postoperative absolute lymphocyte count (P<0.001), hemoglobin (P=0.016), and albumin (P<0.001) levels of the EN group were higher than those of the TPN group, but the postoperative hospital stay time (P=0.008) and the complication rate (P=0.03) in the EN group were less than those in the TPN group. Logistic regression analysis showed that age (P=0.031), American Society of Anesthesiologists (ASA) score (P=0.008), and EN (P=0.024) were independent risk factors for postoperative hospital stay in PMP patients. ASA score (P=0.006), number of prior operations (P=0.021), and EN (P=0.035) were independent risk factors for postoperative complications in PMP patients. Conclusions: EN support results in better outcomes and is an independent protective factor for the postoperative hospital stay time and complications of PMP patients. 2022 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Pseudomyxoma peritonei (PMP); enteral nutrition (EN); parenteral nutrition (TPN); postoperative complications

Year:  2022        PMID: 35694101      PMCID: PMC9177278          DOI: 10.21037/gs-22-170

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  31 in total

1.  Outcome differences between debulking surgery and cytoreductive surgery in patients with Pseudomyxoma peritonei.

Authors:  H Andréasson; W Graf; P Nygren; B Glimelius; H Mahteme
Journal:  Eur J Surg Oncol       Date:  2012-07-17       Impact factor: 4.424

Review 2.  Management of pseudomyxoma peritonei.

Authors:  Simon A Fallis; Brendan J Moran
Journal:  J BUON       Date:  2015-05       Impact factor: 2.533

Review 3.  Update on the management of malignant peritoneal mesothelioma.

Authors:  Paul H Sugarbaker
Journal:  Transl Lung Cancer Res       Date:  2018-10

4.  Enteral feeding in head and neck cancer patients at a UK cancer centre.

Authors:  C H Sheth; S Sharp; E R Walters
Journal:  J Hum Nutr Diet       Date:  2013-02-05       Impact factor: 3.089

Review 5.  Pseudomyxoma peritonei syndrome of appendiceal origin: an overview.

Authors:  Carol Brueggen; Gayle Baird; Allison Meisheid
Journal:  Clin J Oncol Nurs       Date:  2007-08       Impact factor: 1.027

Review 6.  Enteral versus parenteral nutrition in cancer patients: evidences and controversies.

Authors:  Paolo Cotogni
Journal:  Ann Palliat Med       Date:  2016-01

Review 7.  Enteral nutrition support to treat malnutrition in inflammatory bowel disease.

Authors:  Roberta Altomare; Giuseppe Damiano; Alida Abruzzo; Vincenzo Davide Palumbo; Giovanni Tomasello; Salvatore Buscemi; Attilio Ignazio Lo Monte
Journal:  Nutrients       Date:  2015-03-25       Impact factor: 5.717

8.  Recent Advances in Enteral Nutrition.

Authors:  Omorogieva Ojo; Joanne Brooke
Journal:  Nutrients       Date:  2016-11-08       Impact factor: 5.717

Review 9.  Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines.

Authors:  Annika Reintam Blaser; Joel Starkopf; Waleed Alhazzani; Mette M Berger; Michael P Casaer; Adam M Deane; Sonja Fruhwald; Michael Hiesmayr; Carole Ichai; Stephan M Jakob; Cecilia I Loudet; Manu L N G Malbrain; Juan C Montejo González; Catherine Paugam-Burtz; Martijn Poeze; Jean-Charles Preiser; Pierre Singer; Arthur R H van Zanten; Jan De Waele; Julia Wendon; Jan Wernerman; Tony Whitehouse; Alexander Wilmer; Heleen M Oudemans-van Straaten
Journal:  Intensive Care Med       Date:  2017-02-06       Impact factor: 17.440

Review 10.  Parenteral Nutrition: Amino Acids.

Authors:  Leonard John Hoffer
Journal:  Nutrients       Date:  2017-03-10       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.